drug pricing

AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
BioSpace
AstraZeneca
Bristol Myers Squibb
drug pricing
Inflation Reduction Act
Medicare
Flag link:
The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021
The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021
Drug Channels
340B
drug pricing
Flag link:
Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox
Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox
Fierce Pharma
Revance Therapeutics
Daxxify
AbbVie
Botox
drug pricing
Flag link:
DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations
DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations
BioSpace
DOJ
Inflation Reduction Act
drug pricing
Medicare
legal
Flag link:
How Payers Are Reacting to Insulin Price Changes
How Payers Are Reacting to Insulin Price Changes
Drug Channels
payers
insurance
insulin
diabetes
drug pricing
Inflation Reduction Act
Medicare
Flag link:
Is Medicare’s drug-price law affecting the way pharma brands advertise?
Is Medicare’s drug-price law affecting the way pharma brands advertise?
Medical Marketing and Media
DTC adveritising
drug pricing
Inflation Reduction Act
Flag link:
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Reuters
Astellas
Medicare
prostate cancer
Xtandi
drug pricing
Inflation Reduction Act
Flag link:
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Fierce Pharma
Novartis
legal
Inflation Reduction Act
CMS
drug pricing
Entresto
Flag link:
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Medicare Will Soon Negotiate Some Drug Prices. Is This a Threat to Johnson & Johnson's Earnings?
Motley Fool
Medicare
JNJ
drug pricing
Flag link:
US senators push drugmakers for details on low-cost insulin programs
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Senate
insulin
drug pricing
Novo Nordisk
Eli Lilly
Sanofi
diabetes
Flag link:
Novartis hits back at Entresto selection on Medicare list
Novartis hits back at Entresto selection on Medicare list
Pharmaphorum
Novartis
Entresto
drug pricing
Medicare
Flag link:
Biden administration lists 10 drugs for Medicare price negotiation
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Flag link:
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiations
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiations
BioSpace
AstraZeneca
legal
Joe Biden
drug pricing
Inflation Reduction Act
Flag link:
More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement
More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement
Xtalks
Eli Lilly
legal
insulin
Humalog
drug pricing
Arizona
Mississippi
Minnesota
Flag link:
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
BioSpace
Boehringer Ingelheim
drug pricing
legal
Medicare
Inflation Reduction Act
Flag link:
AARP urges courts to keep drug pricing talks on track
AARP urges courts to keep drug pricing talks on track
Yahoo Finance
AARP
legal
HHS
drug pricing
Medicare
CMS
amicus brief
Flag link:
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Fierce Pharma
Eli Lilly
drug pricing
insulin
Humalog
legal
diabetes
Flag link:
Drug pricing concerns cross party lines to become 'core value' for voters, pollsters say
Drug pricing concerns cross party lines to become 'core value' for voters, pollsters say
Fierce Pharma
drug pricing
Inflation Reduction Act
Flag link:
The 10 drugs that CMS might wrangle into negotiations
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Flag link:
Costliest Medicare drugs more than tripled in price since entering market: report
Costliest Medicare drugs more than tripled in price since entering market: report
Axios
drug pricing
Medicare Part D
Inflation Reduction Act
Flag link:

Pages